ARCHIVES

Phase III Ramucirumab Trial Fails Primary Endpoint of PFS

This article is from The Cancer Letter archive.

Vol. 36 No. 10 | October 25, 2013

Download PDF Visit The Full Archive

Related Articles

MSK Investigators Report Sialic Acid Test 95% Accurate; Negative Immunotherapy Results Told

June 13, 1980

Intramural Pis To Control Own Budgets, Have Greater Autonomy, Klausner Says

December 15, 1995

Upper Endoscopy Most Effective When Performed in 3-Year Intervals

July 27, 2012

NCI Seeks CRADA Partners To Develop Targets Drugs

October 24, 1997

Includes May Business & Regulatory Report (8-page issue).

June 6, 2003

RFA For Patterns Of Care Studies Announced By DCCR

November 10, 1978